HK Stock Market Move | QINGSONG HEALTH (02661) Surges Over 5% to Hit a New High. The company recently launched the evidence-based medical intelligent body "Zeng Yuanfang".

QINGSONG HEALTH (02661) rose by more than 5%, reaching a high of 131.5 Hong Kong dollars, an increase of nearly 480% compared to the IPO price of 22.68 Hong Kong dollars. As of the time of writing, it has risen by 5% to 131.5 Hong Kong dollars, with a turnover of 1.19 billion Hong Kong dollars. On the news front, on March 9, QINGSONG HEALTH Group officially launched the evidence-based medical intelligence body "Evidence Yuanfang". This is the first clinical decision support system in China designed with evidence-based medicine as its core methodology, aiming to provide doctors with interpretable, verifiable, and traceable medical decision support. It is worth noting that on March 6, QINGSONG HEALTH was officially included in the Hang Seng Composite Index and simultaneously included in the Hong Kong Stock Connect.